GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » EBITDA Margin %

Noul Co (XKRX:376930) EBITDA Margin % : -16,202.52% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Noul Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Noul Co's EBITDA for the three months ended in Dec. 2024 was ₩-6,174 Mil. Noul Co's Revenue for the three months ended in Dec. 2024 was ₩38 Mil. Therefore, Noul Co's EBITDA margin for the quarter that ended in Dec. 2024 was -16,202.52%.


Noul Co EBITDA Margin % Historical Data

The historical data trend for Noul Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noul Co EBITDA Margin % Chart

Noul Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial -2,419.09 -698.60 -2,135.50 -511.41 -1,252.90

Noul Co Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -551.68 -12,331.47 -4,270.63 -304.80 -16,202.52

Competitive Comparison of Noul Co's EBITDA Margin %

For the Diagnostics & Research subindustry, Noul Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noul Co's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Noul Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Noul Co's EBITDA Margin % falls into.


;
;

Noul Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Noul Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-20064.776/1601.464
=-1,252.90 %

Noul Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-6174.134/38.106
=-16,202.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noul Co  (XKRX:376930) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Noul Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Noul Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Noul Co Business Description

Traded in Other Exchanges
N/A
Address
B-10F, 338, Gwanggyojungang-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16942
Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.

Noul Co Headlines

No Headlines